This tool allows subscribers to track the progress of share prices belonging to all of the key listed animal health companies.
Aratana Therapeutics is progressing R&D work on a candidate that targets the prostaglandin EP4 receptor.
Zoetis and Elanco have both recently received approval for poultry products in the US.
Halfway through 2018, three of the leading animal health players have made great strides in terms of top-line growth. Others have fallen foul of currency exchange issues. Animal Pharm editor Joseph Harvey looks out how the first six months panned out for the top 10.
Phibro Animal Health has recently seen the value of its shares reach a record high.
Phibro Animal Health claims it will see an impact on its bottom line from in-licencing novel companion animal products in the next 18 to 24 months.
US firm Phibro Animal Health has recorded a 9% increase in sales in the fourth quarter of its fiscal 2018, backed by international growth.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.